What Is a Biofilm on Skin and How Do You Manage It?

A biofilm is a structured community of microorganisms that anchors itself to your skin’s surface using a self-produced, slimy protective matrix. Think of it as a microscopic fortress: bacteria (and sometimes fungi) cluster together inside a sticky coating made mostly of sugars, proteins, and DNA, which shields them from your immune system and from treatments like antibiotics. Biofilms show up in chronic wounds, acne lesions, eczema flares, and around medical devices that pass through the skin, and they are a major reason some skin conditions refuse to heal despite standard care.

What a Biofilm Is Made Of

When people picture bacteria on the skin, they usually imagine individual cells floating around freely. That free-floating state, called planktonic, is only part of the story. Under the right conditions, bacteria attach to a surface and begin producing what researchers call extracellular polymeric substances, or EPS. This gooey material is primarily composed of polysaccharides, proteins, and extracellular DNA, all held together in a water-rich matrix.1PubMed Central. Extracellular polymeric substances, a key element in understanding biofilm phenotype The EPS acts as both scaffolding and shield. It gives the community physical structure, keeps nutrients circulating internally, and blocks threats from reaching the bacteria inside.

The composition of the matrix matters because it explains why biofilms behave so differently from loose bacteria. Free-floating bacteria on your skin can be swept away by washing, killed by a topical antibiotic, or mopped up by immune cells. Once those same bacteria build a biofilm, the EPS matrix physically blocks antibodies and white blood cells from making contact. The matrix can also trap and deactivate antimicrobial molecules before they reach the living cells inside. This is the central problem in managing skin biofilms: you are not just fighting bacteria, you are fighting the architecture they built around themselves.

How Biofilms Form on Skin

Biofilm formation follows a general sequence. Individual bacteria first land on a surface and attach loosely. If conditions favor colonization, they begin producing EPS and locking themselves in place. As more cells join and the matrix grows, the community matures into a three-dimensional structure with water channels running through it, almost like a rudimentary circulatory system. Mature biofilms eventually release small clusters of cells that drift to new sites and start the process over again.

On skin, this can happen on intact surfaces, inside hair follicles, in open wounds, or on the surface of implanted devices. The bacteria involved communicate using chemical signals, a process that coordinates their behavior so the community acts more like a single organism than a collection of individuals. The acne-linked bacterium Cutibacterium acnes, for example, carries genes for producing both signaling molecules and the polysaccharides that form the biofilm matrix.2npj Biofilms and Microbiomes. Microbial biofilms and the human skin microbiome This means the bacterium is essentially hard-wired to build biofilms when conditions allow.

Chronic Wounds and Biofilms

The connection between biofilms and chronic wounds is where the clinical stakes get serious. While acute wounds (a fresh cut, a surgical incision) tend to heal in a predictable timeline, chronic wounds stall. Pressure ulcers, diabetic foot ulcers, and venous leg ulcers can persist for months or years, and biofilms are a major reason why. One review found biofilm prevalence rates of roughly 60% in chronic wounds compared with about 6% in acute wounds, and a meta-analysis of 185 chronic non-healing wounds put the average biofilm prevalence even higher, at about 78%.3Oxford Academic. The role of the skin microbiome in wound healing Other researchers describe biofilms as present in virtually all chronic wounds.4PubMed Central. Microbial Biofilms as Barriers to Chronic Wound Healing: Diagnostic Challenges and Therapeutic Advances

Biofilms in wounds do not just sit there passively. They sustain chronic inflammation, which keeps the wound stuck in an unproductive loop: the immune system sends inflammatory signals but cannot clear the biofilm, so the wound never transitions from the inflammatory phase to the repair phase. Wounds containing biofilms made up of multiple bacterial species tend to heal even more slowly than those harboring a single species.5Burns & Trauma. Biofilm delays wound healing: A review of the evidence In diabetic foot ulcers, the problem compounds: high blood sugar, poor blood flow, and nerve damage all create a wound environment that favors biofilm persistence while simultaneously weakening the immune response that might fight it.6PubMed Central. Biofilm-Host Immune Crosstalk at the Diabetic Foot Ulcer Interface: Molecular Mechanisms, Immune Evasion, and Next-Generation Anti-Biofilm Strategies

Biofilms in Acne

Cutibacterium acnes lives on nearly everyone’s skin, but certain strains appear to cause more trouble than others. Research on adolescent acne patients found that inflammatory acne lesions were characterized by reduced bacterial diversity and an overgrowth of C. acnes. Within that species, a specific phylotype (called IA1) was more efficient at adhesion, biofilm production, and tolerating antibiotics than other strains.7PubMed Central. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents The picture that emerges is that biochemical changes in the hair follicle during puberty may give these biofilm-forming strains a competitive advantage, allowing them to crowd out harmless bacteria and ramp up inflammation.

Biofilm formation by C. acnes also helps explain why acne sometimes resists antibiotic treatment. A bacterium shielded inside a biofilm can survive antibiotic concentrations that would easily kill it in its free-floating form. This tolerance contributes to treatment failure and is one reason dermatologists increasingly look beyond antibiotics alone when managing persistent acne.8PubMed Central. The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacterium acnes Biofilms of C. acnes are also a concern in infections around implanted medical devices like joint replacements, where the bacterium colonizes the device surface and proves extremely difficult to eradicate.8PubMed Central. The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacterium acnes

Biofilms and Eczema

Staphylococcus aureus colonizes the skin of most people with atopic dermatitis (eczema), and the severity of the disease tracks with how aggressively those strains produce biofilms. Patients with severe eczema are significantly more likely to be colonized by strong biofilm-producing S. aureus strains compared with those who have milder disease.9Scientific Reports. Inflammatory cytokines and biofilm production sustain Staphylococcus aureus outgrowth and persistence: a pivotal interplay in the pathogenesis of Atopic Dermatitis

The damage goes beyond simple infection. In lab studies, skin cells exposed to S. aureus biofilms lost viability and began dying within just three hours, while the same bacteria in their free-floating form did not cause the same harm over the same timeframe. The dying skin cells trigger a cascade: they release signals that provoke intense itching, recruit immune cells that skew the skin’s response toward allergy-type inflammation, and suppress the skin’s own natural antimicrobial defenses. On top of that, biofilm extracts have been shown to block the normal maturation of skin cells, weakening the skin barrier and leaving it more vulnerable to toxins the bacteria produce.10PubMed Central. Staphylococcal Biofilms in Atopic Dermatitis This creates a vicious cycle: the biofilm damages the skin, the damaged skin becomes easier for bacteria to colonize, and the cycle deepens.

Why Biofilms Are So Hard to Treat

The difficulty is partly physical and partly biological. Physically, the EPS matrix is a barrier. Antibiotics that diffuse easily through liquid can get trapped or neutralized in the sticky matrix before reaching the bacteria at the center. Biologically, bacteria within a biofilm often enter a slow-growth or dormant state. Most antibiotics work by disrupting processes that only active, dividing cells use, so dormant cells survive treatment. These survivors, sometimes called persister cells, can repopulate the biofilm once the antibiotic is removed.4PubMed Central. Microbial Biofilms as Barriers to Chronic Wound Healing: Diagnostic Challenges and Therapeutic Advances

The immune evasion piece is equally important. In healthy skin, your immune system detects invaders and mounts a targeted response. Biofilms interfere with this at multiple levels. The matrix physically blocks immune cells from reaching the bacteria. Some biofilm-forming species actively modulate immune signaling, dampening the response or redirecting it in ways that cause tissue damage without actually clearing the infection. In diabetic wounds, where the immune system is already compromised, biofilms exploit the weakened defenses even further through mechanisms like intracellular persistence, where S. aureus hides inside the patient’s own cells.6PubMed Central. Biofilm-Host Immune Crosstalk at the Diabetic Foot Ulcer Interface: Molecular Mechanisms, Immune Evasion, and Next-Generation Anti-Biofilm Strategies

Detecting Biofilms

One practical challenge is that biofilms on skin are usually invisible to the naked eye. A wound may look clean under normal light but still harbor significant bacterial communities within the tissue. Traditionally, confirming a biofilm required taking a tissue sample and sending it to a lab for microscopy or culture, which takes time and does not always capture what is happening across the entire wound surface.

Newer point-of-care devices use fluorescence imaging to detect bacteria in real time. These handheld devices shine specific wavelengths of light on the wound, and certain bacteria fluoresce in response, revealing their location and density without the need for a biopsy. A systematic review evaluating these tools found that autofluorescence imaging was more accurate than standard visual inspection or clinical signs alone in detecting bacterial burden.11PubMed Central. The Clinical Utility of Autofluorescence Imaging for Bacterial Detection in Wounds: A Systematic Review One such device can map bacterial distribution within seconds and track changes over days or months, helping clinicians decide where to debride and whether treatment is working.12PLoS ONE. Point-of-Care Autofluorescence Imaging for Real-Time Sampling and Treatment Guidance of Bioburden in Chronic Wounds: First-in-Human Results These tools are not yet universal in wound care clinics, but they represent a significant step beyond guesswork.

Current Management Strategies

Because biofilms resist standard antibiotics, managing them on skin usually requires a multi-pronged approach. The frontline intervention for wound biofilms is debridement: physically removing dead tissue, debris, and as much of the biofilm as possible. Debridement aims to convert a stalled chronic wound back into something resembling an acute wound that can restart the healing process. The catch is that biofilms can reform quickly after debridement, so it often needs to be repeated and combined with other treatments.13PubMed Central. Biofilms and Chronic Wounds: Pathogenesis and Treatment Options

Several adjunctive treatments are used alongside debridement:

For acne-related biofilms, the approach differs. Retinoids, benzoyl peroxide, and combination topical therapies are the mainstays. Benzoyl peroxide works as an oxidizing agent that can penetrate biofilms to some degree, and retinoids alter the follicular environment in ways that make biofilm formation less favorable. Prolonged courses of antibiotics, once common, are falling out of favor partly because biofilm tolerance renders them less effective and partly because of antibiotic resistance concerns.

Enzyme-Based Approaches

One of the more promising strategies for dealing with biofilm specifically targets the matrix rather than the bacteria themselves. Since the EPS matrix contains large amounts of extracellular DNA and proteins, enzymes that break down these components can weaken or dissolve the structure. Researchers have shown that DNase (which degrades DNA) and proteinase K (which degrades proteins) can disassemble biofilm matrices, exposing the bacteria inside to antimicrobials.17PubMed Central. Facile Biofilm Penetration of Cationic Liposomes Loaded with DNase I/Proteinase K to Eradicate Cutibacterium acnes for Treating Cutaneous and Catheter Infections In laboratory tests, DNase effectively suppressed biofilm formation by both Pseudomonas aeruginosa and S. aureus, two of the most common wound pathogens.18British Journal of Dermatology. DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus

The practical challenge is delivering these enzymes to the right place at the right concentration. Some research groups are packaging them in tiny lipid-based carriers that can penetrate the biofilm more effectively than free enzymes in solution. These delivery systems are still in the experimental stage, but the concept of attacking the matrix architecture rather than the bacteria directly is gaining traction as a complement to conventional antimicrobials.

Phage Therapy and Endolysins

Bacteriophages, viruses that infect and kill specific bacteria, have attracted renewed attention as biofilm treatments. Phages have a natural advantage: many produce enzymes that bore through biofilm matrices to reach the bacteria inside. Unlike broad-spectrum antibiotics, phages are highly specific, meaning they can target pathogenic bacteria like S. aureus or P. aeruginosa without disturbing the rest of the skin’s microbial community.19Journal of Mycology and Infection. Bacteriophage and Endolysin Therapy for Skin Dysbiosis, Mechanistic Insights, and Therapeutic Applications

Endolysins, enzymes derived from phages, can work independently of the phage itself. In animal models, phage-derived lysins effectively treated P. aeruginosa skin infections.20PubMed Central. Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection The appeal of endolysins for skin biofilms is that they kill bacteria rapidly, they can be engineered for specific pathogens, and resistance to them appears to develop far less readily than resistance to antibiotics. Clinical trials in humans are still limited, but the preclinical data is encouraging enough that several companies are developing topical phage and endolysin products for wounds and skin infections.

Cold Plasma and Photodynamic Therapy

Two physical approaches are also being explored for skin biofilms. Photodynamic therapy uses a light-sensitive compound applied to the skin and then activated by a specific wavelength of light, producing reactive oxygen species that kill bacteria. Cold atmospheric plasma generates a stream of ionized gas at or near room temperature that can damage biofilm structures and kill embedded bacteria. A study testing these methods against biofilms found that combining cold plasma with photodynamic therapy was more effective than either treatment alone.21Scientific Reports. Cold atmospheric plasma degrades methylene blue and shifts bacterial inactivation during photodynamic therapy

Both techniques have the advantage of working through mechanisms that bacteria struggle to develop resistance against. They are not yet routine in dermatology clinics, but cold plasma devices are already used in some wound care centers in Europe, and photodynamic therapy is well established for certain non-biofilm skin conditions like precancerous lesions. Adapting them for biofilm-specific applications is an active area of research.

Probiotics as a Preventive Strategy

Rather than destroying biofilms after they form, another line of research asks whether beneficial bacteria applied to the skin can prevent pathogenic biofilms from establishing in the first place. In laboratory experiments, several probiotic strains applied topically were able to prevent biofilm formation by skin pathogens. One species, Propioniferax innocua, even broke down mature biofilms that had already formed.22Wiley Online Library / PubMed Central. Topical application of probiotics in skin: adhesion, antimicrobial and antibiofilm in vitro assays The idea is that friendly bacteria can compete for attachment sites, produce their own antimicrobial compounds, and disrupt the signaling that pathogenic species use to coordinate biofilm construction.

Topical probiotics for skin are still in early-stage research, and the gap between lab results and reliable clinical products remains wide. Skin is a harsher environment for introduced bacteria than the gut, and keeping beneficial strains alive and active on the skin surface long enough to do their job is a formulation challenge. Still, the concept aligns with a broader shift in dermatology toward microbiome-friendly approaches that restore balance rather than sterilize the skin entirely.

Biofilms Around Percutaneous Devices

Any device that passes through the skin creates an entry point for bacteria, and biofilms are responsible for most infections at these exit sites in short-term devices.23PubMed. A model for studying epithelial attachment and morphology at the interface between skin and percutaneous devices Catheters, external fixation pins, and even continuous glucose monitors all create a skin-device interface where bacteria can colonize and build biofilms. The problem is geometric: even a tiny gap between the skin and the device surface provides a sheltered niche where bacteria are protected from immune surveillance and topical antiseptics.

One approach to this problem is developing device materials that encourage skin cells to seal tightly around the device, eliminating the gap. Another is coating devices with antimicrobial or anti-adhesive surfaces that prevent bacteria from attaching in the first place. Both strategies aim to stop the biofilm before it starts, because once a biofilm is established on an implanted device, removing it usually requires removing the device itself.